Beryl Drugs Limited announced earnings results for the first quarter ended June 30, 2021. For the first quarter, the company announced total revenue was INR 46.483 million compared to INR 27.016 million a year ago. Operating income was INR 2.985 million compared to operating loss of INR 1.741 million a year ago. Net income was INR 3.395 million compared to net loss of INR 1.960 million a year ago. Basic earnings per share from continuing operations was INR 0.67 compared to basic loss per share from continuing operations of INR 0.39 a year ago.